Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Maclean

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Bioorganic & Medicinal Chemistry Letters|August 9, 2016
Discovery and structure-activity relationships of a novel isothiazolone class of bacterial type II topoisomerase inhibitorsIan R Cooper, Andrew J McCarroll, David McGarry, et al.
Cancer Discovery|August 9, 2014
Discovery of biomarkers predictive of GSI response in triple-negative breast cancer and adenoid cystic carcinomaAlexander Stoeck, Serguei Lejnine, Andrew Truong, et al.
ACS Medicinal Chemistry Letters|February 20, 2020
Discovery of <i>N</i>-(Indazol-3-yl)piperidine-4-carboxylic Acids as RORγt Allosteric Inhibitors for Autoimmune DiseasesHongjun Zhang, Blair T Lapointe, Neville Anthony, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2011
Structure-activity studies of a novel series of isoxazole-3-carboxamide derivatives as TRPV1 antagonistsRonald Palin, Lynn Abernethy, Nasrin Ansari, et al.
Bioorganic & Medicinal Chemistry Letters|July 5, 2011
Discovery of potent, soluble and orally active TRPV1 antagonists. Structure-activity relationships of a series of isoxazolesPaul Ratcliffe, Lynn Abernethy, Nasrin Ansari, et al.
British Journal of Sports Medicine|December 28, 2020
Interassociation consensus recommendations for pitch-side emergency care and personal protective equipment for elite sport during the COVID-19 pandemicLisa Hodgson, Gemma Phillips, Jonathan Gordon, et al.
ACS Medicinal Chemistry Letters|May 26, 2015
Discovery of Benzimidazole CYP11B2 Inhibitors with in Vivo Activity in Rhesus MonkeysScott B Hoyt, Min K Park, Clare London, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Bioorganic & Medicinal Chemistry Letters|August 9, 2016
Discovery and structure-activity relationships of a novel isothiazolone class of bacterial type II topoisomerase inhibitorsIan R Cooper, Andrew J McCarroll, David McGarry, et al.
Cancer Discovery|August 9, 2014
Discovery of biomarkers predictive of GSI response in triple-negative breast cancer and adenoid cystic carcinomaAlexander Stoeck, Serguei Lejnine, Andrew Truong, et al.
ACS Medicinal Chemistry Letters|February 20, 2020
Discovery of <i>N</i>-(Indazol-3-yl)piperidine-4-carboxylic Acids as RORγt Allosteric Inhibitors for Autoimmune DiseasesHongjun Zhang, Blair T Lapointe, Neville Anthony, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2011
Structure-activity studies of a novel series of isoxazole-3-carboxamide derivatives as TRPV1 antagonistsRonald Palin, Lynn Abernethy, Nasrin Ansari, et al.
Bioorganic & Medicinal Chemistry Letters|July 5, 2011
Discovery of potent, soluble and orally active TRPV1 antagonists. Structure-activity relationships of a series of isoxazolesPaul Ratcliffe, Lynn Abernethy, Nasrin Ansari, et al.
British Journal of Sports Medicine|December 28, 2020
Interassociation consensus recommendations for pitch-side emergency care and personal protective equipment for elite sport during the COVID-19 pandemicLisa Hodgson, Gemma Phillips, Jonathan Gordon, et al.
ACS Medicinal Chemistry Letters|May 26, 2015
Discovery of Benzimidazole CYP11B2 Inhibitors with in Vivo Activity in Rhesus MonkeysScott B Hoyt, Min K Park, Clare London, et al.
Pageof 3